Atlas Trials

Place of 68Ga-PSMA-11 PET-CT in the Therapeutic Decision at the End of the Initial Staging for High Risk Prostate Cancer Patients

Clinical trial NCT03344822 · UNKNOWN

Trial details

NCT number
NCT03344822
Sponsor
Central Hospital, Nancy, France
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2018-01-02
Primary completion
2018-12-31
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.